| Name | Title | Contact Details |
|---|
DiagnoCure (TSX: CUR; OTCQX: DGCRF) is a life sciences corporation that develops and commercializes high-value cancer diagnostic tests that increase clinician and patient confidence in making critical treatment decisions. In 2008, the Corporation launched a colorectal cancer staging test through its U.S. CLIA laboratory. PrevistageTM GCC is currently available for licensing. The Corporation has granted a worldwide exclusive license on the diagnostic applications of its proprietary molecular biomarker PCA3 to Gen-Probe, now a wholly-owned subsidiary of Hologic Inc. Hologic Gen-Probe's PROGENSA® PCA3 prostate cancer test is commercialized in Europe under CE mark and is approved for commercialization in Canada and the United States.
Boston Ivf is a Waltham, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
As part of the Manning Regional Healthcare Center`s comprehensive total health care system, the Hospital has state-of-the-art diagnostic radiology equipment, emergency department care, inpatient medical and surgical treatment and skilled nursing services. All of this and much more allows us to care for the majority of your medical needs right here in Manning.
Accelovance Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Rockville, MD. To find more information about Accelovance Inc., please visit www.accelovance.com
Halfpenny Technologies, Inc. provides clinical labs, hospitals, accountable care organizations (ACOs), health plans, health information exchanges (HIEs) and EHR vendors with a cloud-based, secure, scalable and vendor-neutral clinical data exchange platform designed to optimize patient care coordination while reducing waste. We have a long-standing, proven track record of providing advanced features, rapid implementation, reliable technology infrastructure and LOINC mapping that enables laboratories and hospitals to win new accounts and improve service to existing clients